Cargando…
Effect of rivastigmine as an adjunct to usual care with haloperidol on duration of delirium and mortality in critically ill patients: a multicentre, double-blind, placebo-controlled randomised trial
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2011
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3067013/ http://dx.doi.org/10.1186/cc9759 |
| _version_ | 1782201160616116224 |
|---|---|
| author | Van Eijk, MM Roes, KC Honing, ML Kuiper, MA Karakus, A Van der JAgt, M Spronk, PE Van Gool, WA Van der Mast, RC Kesecioglu, J Slooter, AJ |
| author_facet | Van Eijk, MM Roes, KC Honing, ML Kuiper, MA Karakus, A Van der JAgt, M Spronk, PE Van Gool, WA Van der Mast, RC Kesecioglu, J Slooter, AJ |
| author_sort | Van Eijk, MM |
| collection | PubMed |
| description | |
| format | Text |
| id | pubmed-3067013 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2011 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-30670132011-03-31 Effect of rivastigmine as an adjunct to usual care with haloperidol on duration of delirium and mortality in critically ill patients: a multicentre, double-blind, placebo-controlled randomised trial Van Eijk, MM Roes, KC Honing, ML Kuiper, MA Karakus, A Van der JAgt, M Spronk, PE Van Gool, WA Van der Mast, RC Kesecioglu, J Slooter, AJ Crit Care Poster Presentation BioMed Central 2011 2011-03-11 /pmc/articles/PMC3067013/ http://dx.doi.org/10.1186/cc9759 Text en Copyright ©2011 Van Eijk et al. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Poster Presentation Van Eijk, MM Roes, KC Honing, ML Kuiper, MA Karakus, A Van der JAgt, M Spronk, PE Van Gool, WA Van der Mast, RC Kesecioglu, J Slooter, AJ Effect of rivastigmine as an adjunct to usual care with haloperidol on duration of delirium and mortality in critically ill patients: a multicentre, double-blind, placebo-controlled randomised trial |
| title | Effect of rivastigmine as an adjunct to usual care with haloperidol on duration of delirium and mortality in critically ill patients: a multicentre, double-blind, placebo-controlled randomised trial |
| title_full | Effect of rivastigmine as an adjunct to usual care with haloperidol on duration of delirium and mortality in critically ill patients: a multicentre, double-blind, placebo-controlled randomised trial |
| title_fullStr | Effect of rivastigmine as an adjunct to usual care with haloperidol on duration of delirium and mortality in critically ill patients: a multicentre, double-blind, placebo-controlled randomised trial |
| title_full_unstemmed | Effect of rivastigmine as an adjunct to usual care with haloperidol on duration of delirium and mortality in critically ill patients: a multicentre, double-blind, placebo-controlled randomised trial |
| title_short | Effect of rivastigmine as an adjunct to usual care with haloperidol on duration of delirium and mortality in critically ill patients: a multicentre, double-blind, placebo-controlled randomised trial |
| title_sort | effect of rivastigmine as an adjunct to usual care with haloperidol on duration of delirium and mortality in critically ill patients: a multicentre, double-blind, placebo-controlled randomised trial |
| topic | Poster Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3067013/ http://dx.doi.org/10.1186/cc9759 |
| work_keys_str_mv | AT vaneijkmm effectofrivastigmineasanadjuncttousualcarewithhaloperidolondurationofdeliriumandmortalityincriticallyillpatientsamulticentredoubleblindplacebocontrolledrandomisedtrial AT roeskc effectofrivastigmineasanadjuncttousualcarewithhaloperidolondurationofdeliriumandmortalityincriticallyillpatientsamulticentredoubleblindplacebocontrolledrandomisedtrial AT honingml effectofrivastigmineasanadjuncttousualcarewithhaloperidolondurationofdeliriumandmortalityincriticallyillpatientsamulticentredoubleblindplacebocontrolledrandomisedtrial AT kuiperma effectofrivastigmineasanadjuncttousualcarewithhaloperidolondurationofdeliriumandmortalityincriticallyillpatientsamulticentredoubleblindplacebocontrolledrandomisedtrial AT karakusa effectofrivastigmineasanadjuncttousualcarewithhaloperidolondurationofdeliriumandmortalityincriticallyillpatientsamulticentredoubleblindplacebocontrolledrandomisedtrial AT vanderjagtm effectofrivastigmineasanadjuncttousualcarewithhaloperidolondurationofdeliriumandmortalityincriticallyillpatientsamulticentredoubleblindplacebocontrolledrandomisedtrial AT spronkpe effectofrivastigmineasanadjuncttousualcarewithhaloperidolondurationofdeliriumandmortalityincriticallyillpatientsamulticentredoubleblindplacebocontrolledrandomisedtrial AT vangoolwa effectofrivastigmineasanadjuncttousualcarewithhaloperidolondurationofdeliriumandmortalityincriticallyillpatientsamulticentredoubleblindplacebocontrolledrandomisedtrial AT vandermastrc effectofrivastigmineasanadjuncttousualcarewithhaloperidolondurationofdeliriumandmortalityincriticallyillpatientsamulticentredoubleblindplacebocontrolledrandomisedtrial AT keseciogluj effectofrivastigmineasanadjuncttousualcarewithhaloperidolondurationofdeliriumandmortalityincriticallyillpatientsamulticentredoubleblindplacebocontrolledrandomisedtrial AT slooteraj effectofrivastigmineasanadjuncttousualcarewithhaloperidolondurationofdeliriumandmortalityincriticallyillpatientsamulticentredoubleblindplacebocontrolledrandomisedtrial |